Luo, R., Yu, M., Kang, K., Zhang, Y., Liu, S., Yao, Z., Peng, Z., Zhang, X., Liao, S., Su, Z., Yi, L., Wang, H., Zhao, W., Zheng, Y., Lin, G., Tong, R., Na, F., Gong, Y., Huang, M., Zou, B., Bai, L., Zhong, R., Yan, D., Niedermann, G., Xue, J., Lu, Y. (2026). SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis. Nature Communications. https://doi.org/10.1038/s41467-026-73683-z